FCTE vs. THNR ETF Comparison
Comparison of SMI 3Fourteen Full-Cycle Trend ETF (FCTE) to Amplify Weight Loss Drug & Treatment ETF (THNR)
FCTE
SMI 3Fourteen Full-Cycle Trend ETF
FCTE Description
The fund is actively managed and typically owns 20 domestic stocks that are normally included in the S&P 500 Index ("S&P 500"). The FCT strategy is based on a proprietary model developed by 3Fourteen that selects stocks based on quality stock screens and trend factors such as return on capital and cash flow stability, earnings growth, return on investment, momentum, linear regression and trend analysis. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$26.40
Average Daily Volume
105,642
20
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$22.58
Average Daily Volume
2,478
15
Performance
| Period | FCTE | THNR |
|---|---|---|
| 30 Days | -3.98% | -12.44% |
| 60 Days | -1.33% | -16.42% |
| 90 Days | -2.32% | -14.44% |
| 12 Months |
0 Overlapping Holdings
| Symbol | Grade | Weight in FCTE | Weight in THNR | Overlap |
|---|
FCTE Overweight 20 Positions Relative to THNR
FCTE: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
